HBAN vs IVF · P/E 13, rev $1.56B vs rev $2.2M
Huntington Bancshares Incorporated (HBAN) versus INVO Fertility, Inc. (IVF) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
INVO Fertility, Inc. (IVF) is a medical devices company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported IVF revenue for 2026-06-30 was $2.2M. Net income was $888.7K. Revenue was up 8.0% from 2026-03-31 to 2026-06-30. IVF currently screens at market cap $2.8M.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. IVF currently screens at market cap $2.8M.
Not investment advice. Open the HBAN and IVF stock pages for the full models.
Not investment advice.